• Services
    • Overview
    • Antibody Profiling Solutions
    • Oncology Drug Screening
    • Immunoprofiling
    • Vaccine Development
    • Custom Protein Arrays
  • Applications
        • Disease Area
          • Autoimmune Disease
          • Immuno-Oncology
          • Neurological Disease
          • Infectious Disease
        • Application Area
          • Biomarker Discovery
          • Patient Stratification
          • Disease and Treatment Outcome Prediction
          • Diagnostics & CDx Development
  • Technology
    • Overview
    • KREX Protein Folding Technology
    • Antibodies as Biomarkers
    • Bioinformatics for Antibody Profiling
  • Resources
    • Blog
    • Videos
    • Featured Publications
    • Product Information
    • White Paper & Case Studies
    • Protein List
    • FAQs
  • About
    • Company Overview
      • Patents
    • Meet Our Team
    • News & Events
  • Menu Menu
  • Join Our Team
  • Contact

Patents

Building on a strong IP foundation

Sengenics has robust intellectual property (IP) protection for its innovations in key application areas in multiple jurisdictions worldwide.

  • Biomarkers
  • Core Technology Patents
  • Companion Diagnostics Patents
  • Sero-Diagnostics Patents

Biomarkers

  • Patent Number
  • Descriptions
  • View Patent

EP2022782935

Biomarkers View Patent

GB2113264.2

Biomarkers View Patent

WO/2023/041932

Biomarkers View Patent

Core Technology Patents

  • Patent Number
  • Descriptions
  • View Patent

EP1485411

Arrays of cytosolic accessory proteins immobilized on a surface and pertinent methods View Patent

JP4730804

Generating protein arrays View Patent

PCT/US2023/085687

Low surface density functional protein arrays View Patent

GB2219735.4

Low surface density functional protein arrays View Patent

US7816098

Methods of making and using a protein array View Patent

JP4377242

Methods of determining method, and a folded state to increase the protein tag, and solubility including biotinylation domain View Patent

GB2361698

Modification of DNA molecules View Patent

US20180305840

Protein arrays and their use to assay the protein products of highly homologous or related DNA coding sequences View Patent

JP4781628/JP2005512055

Protein arrays and their use for the allelic variants View Patent

US8999897

Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state View Patent

EP1470229

Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state View Patent

CA2474457

Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state View Patent

AU2003238441

Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state View Patent

EP1456668

Protein arrays for allelic variants and uses thereof View Patent

CA2469403

Protein arrays for allelic variants and uses thereof View Patent

AU2002352355

Protein arrays for allelic variants and uses thereof View Patent

Companion Diagnostics Patents

  • Patent Number
  • Descriptions
  • View Patent

JP2023530745

Biomarkers for predicting immunogenicity and therapeutic responses to adalimumab in rheumatoid arthritis patients View Patent

HK40091345

Biomarkers for predicting immunogenicity and therapeutic responses to adalimumab in rheumatoid arthritis patients View Patent

20240027444

Biomarkers for predicting immunogenicity and therapeutic responses to adalimumab in rheumatoid arthritis patients View Patent

CN117716236

Biomarkers for predicting immunogenicity and therapeutic responses to adalimumab in rheumatoid arthritis patients View Patent

CA3199484

Biomarkers for predicting immunogenicity and therapeutic responses to adalimumab in rheumatoid arthritis patients View Patent

SG10202011473Y

Biomarkers for predicting immunogenicity and therapeutic responses to adalimumab in rheumatoid arthritis patients View Patent

EP2021895241

Biomarkers for predicting immunogenicity and therapeutic responses to adalimumab in rheumatoid arthritis patients View Patent

KR1020237020390

Biomarkers for predicting immunogenicity and therapeutic responses to adalimumab in rheumatoid arthritis patients View Patent

AU2021383283

Biomarkers for predicting immunogenicity and therapeutic responses to adalimumab in rheumatoid arthritis patients View Patent

10202011473Y

Biomarkers for predicting immunogenicity and therapeutic responses to adalimumab in rheumatoid arthritis patients View Patent

WO/2022/108522

Biomarkers for predicting immunogenicity and therapeutic responses to adalimumab in rheumatoid arthritis patients View Patent

Sero-Diagnostics Patents

  • Patent Number
  • Descriptions
  • View Patent

WO/2020/122817

Detection of biomarkers for Non-Small Cell Lung Cancer View Patent

HK40063027

Detection of biomarkers for Non-Small Cell Lung Cancer View Patent

CA3123382

Detection of biomarkers for Non-Small Cell Lung Cancer  View Patent

US20220260571

Detection of biomarkers for Non-Small Cell Lung Cancer  View Patent

JP2022513928

Detection of biomarkers for Non-Small Cell Lung Cancer  View Patent

CN113614536

Detection of biomarkers for Non-Small Cell Lung Cancer  View Patent

EP3894861

Detection of biomarkers for Non-Small Cell Lung Cancer  View Patent

KR1020210104073

Detection of biomarkers for Non-Small Cell Lung Cancer  View Patent

MYPI 2021003281

Detection of biomarkers for Non-Small Cell Lung Cancer  View Patent

AU2019395619

Detection of biomarkers for Non-Small Cell Lung Cancer  View Patent

SG10201811119X

Detection of biomarkers for Non-Small Cell Lung Cancer  View Patent

WO/2021/061048

Identification of health status in the elderly using immunological biomarkers View Patent

HK40069871

Identification of health status in the elderly using immunological biomarkers View Patent

JP2022550377

Identification of health status in the elderly using immunological biomarkers View Patent

US17763572

Identification of health status in the elderly using immunological biomarkers View Patent

CN114761808

Identification of health status in the elderly using immunological biomarkers View Patent

EP2020868311

Identification of health status in the elderly using immunological biomarkers View Patent

KR1020220069032

Identification of health status in the elderly using immunological biomarkers View Patent

CA3152465

Identification of health status in the elderly using immunological biomarkers View Patent

MYPI 2022001597

Identification of health status in the elderly using immunological biomarkers View Patent

AU2020356141

Identification of health status in the elderly using immunological biomarkers View Patent

SG10201908922U

Identification of health status in the elderly using immunological biomarkers View Patent

IN201741015794

Method for detection and diagnosis of Oral Cancer in a sample View Patent

AU2018100578A4

Method for detection and diagnosis of Oral Cancer in a sample View Patent

US20180321244A1

Method for detection and diagnosis of Oral Cancer in a sample View Patent

Ready to accelerate your program?

Let’s discuss your needs

  • Services
  • Applications
  • Technology
  • Resources
  • About

Sengenics, a functional proteomics company, is committed to advancing precision medicine by empowering researchers with biologically relevant and actionable immunoproteomic insights across a broad spectrum of diseases. At the heart of its mission, Sengenics offers advanced, high-throughput tools using proprietary technology to precisely detect autoantibody biomarkers and protein interactions for basic, translational, and clinical research. Its robust tools have been leveraged by top pharmaceutical companies and leading research institutions to enhance disease understanding and streamline the biomarker pipeline.

© 2024 Sengenics Corporation LLC. All rights reserved. Sengenics Corporation LLC. Registered in Delaware, USA no. 5739583 | Sengenics Corporation Pte Ltd. Registered in Singapore no. 201734100D

Terms & Conditions | Terms of Use | Privacy Statement | Cookie Policy | Code of Conduct | Whistleblowing Policy | Sitemap

Design and development by RainCastle Communications.

"*" indicates required fields

Fill in the form to download the publication

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Watch the video

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Watch the video

"*" Indicates required fields

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Autoantibody-Based Diagnostic Biomarkers: Technological Approaches to Discovery and Validation


Read the Review

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Watch the video

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.